Loading...

Table of Content

    25 December 2025, Volume 24 Issue 06 Previous Issue   
    For Selected: Toggle Thumbnails
    Expert forum
    Advances in sepsis screening technologies
    LIU Gan, DAI Yuanyuan, CHANG Wenjiao, MA Xiaoling
    2025, 24 (06):  567-575.  DOI: 10.16150/j.1671-2870.2025.06.001
    Abstract ( 26 )   HTML ( 2 )   PDF (546KB) ( 18 )  

    Sepsis is a life-threatening syndrome of organ dysfunction caused by a dysregulated systemic inflammatory response to infection. Early recognition and precise intervention are crucial for improving the prognosis of sepsis patients. In recent years, significant progress has been made in technologies related to sepsis, such as etiological identification, host-response assessment, and intelligent-assisted diagnosis, enhancing the diagnosis and treatment capability of sepsis. This review provides a systematic overview of advances in etiological identification [such as rapid mass spectrometry identification of positive blood culture, metagenomic next-generation sequencing (mNGS), droplet digital polymerase chain reaction (ddPCR), and T2 magnetic resonance], the application of host-response monitoring markers [such as procalcitonin (PCT), interleukin-6 (IL-6), monocyte human leukocyte antigen-DR (mHLA-DR), and emerging non-coding RNAs] in infection recognition and immune monitoring, and the roles of multi-omics (transcriptomics, proteomics, and metabolomics) and artificial intelligence (AI) technologies in early warning, endotyping, and individualized therapy of sepsis. Additionally, this review highlights the current limitations of sepsis screening technologies, and outlines future directions for cross-disciplinary collaboration to promote precise screening and clinical translation.

    References | Related Articles | Metrics
    Further discussion on clinical report thresholds for pathogen metagenomic next-generation sequencing
    WU Wenjuan, TIAN Wenjie, GOU Xuejing
    2025, 24 (06):  576-582.  DOI: 10.16150/j.1671-2870.2025.06.002
    Abstract ( 24 )   HTML ( 1 )   PDF (829KB) ( 25 )  

    In recent years, pathogen metagenomic next-generation sequencing (mNGS) technology has been widely applied in the etiological diagnosis of complex, severe, and atypical infections, addressing the limitations of conventional detection methods. However, the clinical interpretation of mNGS results relies highly on the setting of thresholds, and currently there is no unified standard. The individualized setting of clinical report thresholds for pathogen mNGS requires comprehensive consideration of technical factors, such as pathogen characteristics, background microbial baseline, and genome coverage, as well as multiple clinical factors, including host status, clinical symptoms, sample type, and treatment response. The ultimate goal is to provide more clinically informative etiological diagnoses. From the perspective of the clinical laboratory, the current status and challenges of clinical report threshold setting for pathogen mNGS are reviewed, the differential logic of threshold setting across different pathogen categories is analyzed, and the future development directions towards personalized and intelligent approaches in setting mNGS clinical report thresholds for clinical practice are explored.

    Figures and Tables | References | Related Articles | Metrics
    Current status and challenges in sepsis diagnosis and treatment
    HUANG Man, DING Shuo
    2025, 24 (06):  583-592.  DOI: 10.16150/j.1671-2870.2025.06.003
    Abstract ( 21 )   HTML ( 0 )   PDF (538KB) ( 14 )  

    Sepsis leads to approximately 11 million deaths globally each year, and its incidence is still on the rise, particularly in aging societies. Elderly patients, due to multiple underlying diseases and declined immune function, often progress rapidly to sepsis after infection, resulting in poor prognosis. Additionally, immunosuppressed patients, such as those who have undergone organ transplantation or have malignant tumors, exhibit a significantly higher incidence of sepsis compared to the general population. From 2017 to 2019, the annual standardized incidence of sepsis among hospitalized patients in China was (328.25-421.85) per 100 000, with over 57% of cases occurring in individuals aged 65 and above. As a syndrome of organ dysfunction caused by a systemic hyperinflammatory response to infection, sepsis remains a significant disease contributing to high mortality and healthcare burden worldwide. Although diagnostic and therapeutic strategies have been continuously improved with in-depth research on sepsis mechanisms in recent years, clinical practice still faces several core challenges: ① difficulties in early diagnosis due to limitations of current assessment systems and biomarkers; ② increasingly severe antibiotic resistance, which significantly restricts treatment options; and ③ extremely high heterogeneity of the disease, which leads to poor efficacy of standardized treatment schemes and limited adoption of individualized therapy. In recent years, at the diagnostic level, the application of novel biomarkers, molecular diagnostic technologies, and artificial intelligence is driving innovations in early identification and precise subtyping capabilities. At the therapeutic level, the concepts of individualized and precision medicine are increasingly applied, and novel therapeutic strategies such as immunomodulation demonstrate great potential in addressing disease complexity. The key to overcoming the above three core challenges lies in integrating the concept of precision medicine throughout the entire diagnostic and therapeutic process: by leveraging multi-omics data to deepen the understanding of disease heterogeneity, utilizing advanced technologies to achieve accurate diagnosis and subtyping, and developing targeted therapies based on this foundation, ultimately achie-ving the goal of improving patient prognosis.

    Figures and Tables | References | Related Articles | Metrics
    Academic trend at home and abroad
    Progress in diagnosis and treatment of psoriasis from 2023 to 2024
    DAI Min, JIANG Yuxiong, SHI Yuling
    2025, 24 (06):  593-604.  DOI: 10.16150/j.1671-2870.2025.06.004
    Abstract ( 19 )   HTML ( 0 )   PDF (639KB) ( 11 )  

    The global prevalence of psoriasis is 2%-3%. The prevalence in Western countries falls between 2% and 4%, while it is relatively lower in Asia, ranging from only 0.1% to 0.5%. In the Chinese population, the prevalence of psoriasis is approximately 0.88%, and the incidence is approximately 0.74%. From 2023 to 2024, significant progress has been achieved across multiple aspects of diagnosis and treatment of psoriasis. In terms of diagnosis, international guidelines have further standardized the criteria for assessing disease severity. Diagnostic criteria for pustular psoriasis have been continuously improved, and the concept of disease modification has been gradually established, providing directions for achieving long-term management goals. The application of artificial intelligence (AI) and digital technologies in assisted diagnosis has become increasingly widespread, promoting the clinical translation of new tools such as automatic lesion recognition, prediction of psoriasis area and severity index (PASI) score, and remote assessment. Regarding comorbidity management, the research focus has shifted from single screening to multi-system coordinated intervention, especially in terms of metabolic abnormalities, cardiovascular risk, and mental health, thereby strengthening the patient-centered comprehensive management concept. Treatment strategies have been continuously updated, with real-world evidence for interleukin (IL)-17 and IL-23 pathway-targeting drugs accumulating. Meanwhile, small molecule drugs such as Janus kinase (JAK) inhibitors and tyrosine kinase 2 (TYK2) inhibitors have demonstrated good efficacy and safety in clinical application. In the future, psoriasis management is expected to transition from short-term control to long-term disease modification. Precision diagnosis, individualized treatment, and multidimensional comorbidity management will be accelerated through AI and omics technologies, facilitating the establishment of a full-cycle, comprehensive psoriasis diagnosis and treatment system.

    References | Related Articles | Metrics
    Application of artificial intelligence in medical image data processing for digestive tract tumors
    YANG Ruixin, YU Yingyan
    2025, 24 (06):  605-612.  DOI: 10.16150/j.1671-2870.2025.06.005
    Abstract ( 20 )   HTML ( 0 )   PDF (510KB) ( 8 )  

    In recent years, with the rapid development of artificial intelligence (AI) algorithm models, a variety of approaches have emerged, such as convolutional neural networks (CNN) algorithms mainly for image classification, decision trees and support vector machine models for decision classification, attention mechanism models for impro-ving identification accuracy, object detection models for lesion identification and localization in images, and semantic segmentation and instance segmentation models for precise lesion segmentation in images. The deep integration of AI-based CNN with medical imaging has significantly improved the efficiency and accuracy of disease diagnosis. With the improvement of digital medicine, the integration points of image data with AI in disease diagnosis and treatment pathways have further expanded. Besides traditional images, (radiology, ultrasonography, endoscopy, pathology), non-classical images, such as surgical resection specimen images and organoid images, are gradually incorporated into the scope of AI research. The deep involvement of AI helps decode hidden information in multi-dimensional data, conti-nuously transforming disease diagnosis and treatment patterns. In the foreseeable future, the integration of AI algorithms with various disease diagnosis and treatment devices will become powerful tools for disease diagnosis, treatment, and even prediction of development trends.

    Figures and Tables | References | Related Articles | Metrics
    Guideline interpretation
    Interpretation of Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus (2025 Edition)
    DA Zhanyun, CHEN Haiye
    2025, 24 (06):  613-620.  DOI: 10.16150/j.1671-2870.2025.06.006
    Abstract ( 68 )   HTML ( 1 )   PDF (476KB) ( 23 )  

    Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by diverse clinical manifestations, high heterogeneity, and strongly individualized treatment approaches. In 2021, the global incidence of SLE was (1.5-11.0)/100 000 person-years, while in Europe, the incidence was (1.5-7.4)/100 000 person-years. From 2009 to 2016, the incidence of SLE in the United States reached as high as 49/100 000 person-years. From 2013 to 2017 in China, analysis of the national medical insurance database and the National Rheumatology Data Center showed that the incidence of SLE in China was 14.09/100 000 person-years. Data from different countries indicate significant regional differences in the SLE incidence. With the continuous development of new diagnostic concepts and therapeutic drugs, significant progress has been made in SLE treatment strategies. However, problems such as non-standardized diagnosis and insufficient long-term management remain in the diagnosis and treatment practice of SLE in China. The "Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus (2025 Edition)" addresses 12 clinically relevant issues. Based on the latest domestic and international research evidence and China's SLE diagnosis and treatment practice, the guidelines provide evidence-based recommendations tailored to China's national context. These guidelines play a crucial role in promoting the advancement of standardized diagnosis and treatment and in improving the long-term prognosis of SLE patients in China. Compared with the "2020 Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus", the "2025 Edition" has been updated in terms of treatment targets, hormone maintenance doses, management of common organ involvement, therapeutic role of biological therapy, new immunosuppressants, and new treatment methods. This study focuses on interpreting the core recommendations of the guidelines, including SLE treatment targets, disease assessment methods, application of therapeutic drugs (including glucocorticoids, conventional immunosuppressants, and biologics), stratified treatment strategies for common organ involvement (including lupus nephritis, SLE with severe thrombocytopenia, SLE with antiphospholipid syndrome, and neuropsychiatric lupus), and long-term disease management. It aims to help clinicians quickly grasp the latest advances in SLE diagnosis and treatment, promote the implementation of standardized and individualized diagnosis and treatment concepts in clinical practice, and ultimately improve the overall diagnosis and treatment level, quality of life, and long-term survival rate of SLE patients in China.

    Figures and Tables | References | Related Articles | Metrics
    Original articles
    Study on drug resistance of carbapenem-resistant Acinetobacter baumannii in a tertiary hospital in Xinjiang from 2023 to 2024
    JIA Liying, XU Haifeng, YU Chong, GUO Wanhai, LONG Rui
    2025, 24 (06):  621-627.  DOI: 10.16150/j.1671-2870.2025.06.007
    Abstract ( 15 )   HTML ( 0 )   PDF (573KB) ( 8 )  

    Objective To analyze the molecular epidemiological characteristics of carbapenem-resistant Acinetobacter baumannii (CRABA) at Karamay Central Hospital from 2023 to 2024, and to investigate the carriage of carbape-nemase and RND efflux pump genes in CRABA, so as to provide an experimental basis for the clinical prevention, control, and treatment of Acinetobacter baumannii infection in the Xinjiang region. Methods CRABA strains isolated from clinical culture at Karamay Central Hospital from 2023 to 2024 were collected, and percentage of CRABA detected in Acinetobacter baumannii (detection rate) was calculated. PCR was used to detect 10 common carbapenemase genes and RND efflux pump genes. Results A total of 179 CRABA strains were obtained with a detection rate of 79.56%. The majority were detected in the ICU (62.60%) and the respiratory intensive care unit (11.73%). The strains showed high resistance rate to antibiotics, with the highest resistance rate observed for ciprofloxacin (100%), and the lowest for tigecycline (11.73%). The detection of drug resistance genes revealed that among the 179 CRABA strains, the positive carriage rates from high to low were: blaIMP 95.53% (171/179), blaOXA-51 87.71% (157/179), blaTEM 82.12% (147/179), adeB 82.12% (147/179), adeM 80.45% (144/179), adeJ 77.65% (139/179), blaOXA-23 74.86% (134/179), blaNDM-1 8.94% (16/179), blaOXA-58 4.47% (8/179), and blaVIM 0 (0/179). Conclusions The detection rate of CRABA at our hospital from 2023 to 2024 were significantly higher than the national average (2023, 73.4%). The high expression of the carbapenemase genes include blaIMP and blaTEM, and RND efflux pump genes adeB, adeM, and adeJ. This suggests that local clinical practice should strengthen the management of antibiotics and ensure their rational use.

    Figures and Tables | References | Related Articles | Metrics
    Application value of deep learning-based rapid MRCP imaging in examination of patients with breath holding difficulties
    KONG Deyan, GAO Yiyang, Zhang Caoyang, DONG Haipeng, YAN Fuhua, YUAN Ziyang, DAI Jiankun, LIU Fangtao
    2025, 24 (06):  628-633.  DOI: 10.16150/j.1671-2870.2025.06.008
    Abstract ( 15 )   HTML ( 0 )   PDF (1024KB) ( 9 )  

    Objective To compare the image quality of rapid deep learning (RDL)-based three-dimensional (3D) breath holding (BH) magnetic resonance cholangiopancreatography (MRCP) and that of conventional 3D BH MRCP in patients unable to cooperate with breath holding. Methods A total of 50 patients with poor breath holding cooperation who underwent MRCP examination at Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine from January to March 2025 were prospectively enrolled for scanning with 3D BH DLS MRCP(DLS group) and BH 3D MRCP(MRCP group) sequences successively. The scanning duration of the two sequences were compared. Objective analysis including the signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of the images, as well as subjective analysis including the overall image quality, background suppression, and visualization of the pancreatic and biliary ducts in both groups were compared. Results The averge scanning duration was 11 s for the 3D BH DLS MRCP group and 17 s for the 3D BH MRCP group, indicating a significant reduction in scanning time for 3D BH DLS MRCP (P<0.05). Objective analysis revealed that both the SNR (23.76±9.23) and CNR (28.89±11.49) of 3D BH DLS MRCP were higher than those of 3D BH MRCP [(17.15±6.85), (22.03±8.79)] (P<0.05). Subjective image analysis showed that 3D BH DLS MRCP outperformed 3D BH MRCP in overall image quality scores (3.80±0.32 vs 3.10±0.44), background suppression (3.64±0.40 vs 3.33±0.51), and visualization of pancreaticobiliary duct segments (3.53±0.37 vs 3.08±0.56) with an upward trend(P>0.05). Results of all 50 cases in the 3D BH DLS MRCP sequence met the diagnostic requirements, while of 5 cases in the 3D BH MRCP sequence did not, with a statistically significant difference between the two sequences (P<0.05). Conclusions In cases where breath holding is impossible or poorly performed, the use of 3D BH DLS MRCP could significantly shortens examination time, with image quality of the same level as BH 3D MRCP, and meets clinical diagnostic requirements.

    Figures and Tables | References | Related Articles | Metrics
    Analysis of diagnosis and treatment of 9 cases of primary thyroid lymphoma
    LU Hongyu, XU Youhai, XU Hao, LIU Dan, SONG Luxi
    2025, 24 (06):  634-640.  DOI: 10.16150/j.1671-2870.2025.06.009
    Abstract ( 23 )   HTML ( 0 )   PDF (3069KB) ( 16 )  

    Objective To analyze and summarize the clinical and ultrasonographic features, as well as the diagnostic and therapeutic experiences, of patients with primary thyroid lymphoma (PTL). Methods A total of 9 consecutive cases of PTL, confirmed by pathological biopsy and admitted to Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine from October 2022 to December 2024, were collected. A retrospective analysis was conducted on their clinical data, ultrasonographic characteristics, pathological diagnostic methods, and diagnosis and treatment process. Results Among the 9 patients (7 females, 2 males), the median age was 76 years (range: 39-88 years). All patients presented with progressively enlarging neck masses, six cases had obstructive symptoms, and eight cases were complicated with Hashimoto's thyroiditis (HT). Ultrasonography classified cases as: diffuse type (n=2, diffusely enlarged involved lobe with hypoechogenicity, internal linear echoes, and posterior acoustic enhancement), nodular type (n=3, solitary hypoechoic nodules), and mixed type (n=4, glandular enlargement with multifocal hypoechoic lesions). Regarding pathological diagnosis methods, 5 cases were confirmed by fine needle aspiration (FNA) combined with core needle biopsy (CNB), 2 cases were directly diagnosed by CNB, and 2 cases were diagnosed by surgical pathology. All patients initially received immunochemotherapy (R-CHOP/miniCHOP or Pola-R-miniCHP ± Glofit, 6-8 cycles). Three patients with incomplete remission received subsequent involved-site radiotherapy. Among 7 evaluable patients, 4 achieved complete remission (CR), 2 had partial remission (PR), and 1 died of progression after PR. Conclusions When elderly HT patients pre-sent with rapidly enlarged thyroid mass and obstructive symptoms over a short period, the possibility of PTL should be suspected. Characteristic ultrasonographic features include diffuse/nodular hypo-/marked hypoechoic lesions with internal linear hyperechoic strands, posterior acoustic enhancement, abundant vascularity, and absence of calcification. When PTL is clinically suspected, CNB cytology examination is recommended as the preferred method to improve diagnostic accuracy. Comprehensive treatment based on immunochemotherapy with or without radiotherapy can provide a favorable prognosis.

    Figures and Tables | References | Related Articles | Metrics
    Analysis of ultrasonic two-step assessment of postpartum diastasis recti abdominis and related risk factors in parturients at 42-day postpartum
    GAO Yihui, ZHANG Huiping, ZHOU Yuqing
    2025, 24 (06):  641-647.  DOI: 10.16150/j.1671-2870.2025.06.010
    Abstract ( 21 )   HTML ( 1 )   PDF (949KB) ( 13 )  

    Objective To evaluate the incidence and severity of diastasis recti abdominis (DRA) in parturients at the 42-day postpartum and analyze the maternal and infant risk factors associated with postpartum DRA occurrence using a two-step method with conventional two-dimensional ultrasonography. Methods Postpartum women (consecutive cases) who delivered at our hospital and underwent the 42-day postpartum checkups between September and October 2022 were included in this study. All enrolled women first performed curl-up movement under the guidance of a sonographer, and the boundaries of the rectus abdominis were located in the contracted state using conventional two-dimensional ultrasound (first step). Then, the parturients were instructed to lie supine in a relaxed state of rectus abdominis to measure the inter-rectus distances (IRD) (second step). The IRD was measured at three locations: 3 cm above the umbilicus, at the level of the umbilicus, and 3 cm below the umbilicus. The diagnosis of DRA was established and classified into mild, moderate, and severe groups according to the guidelines of the European Hernia Society for DRA management. The incidence of DRA and the proportion of mild, moderate, and severe cases were statistically analyzed. Maternal information (including age) and infant information (including birth weight) were recorded. Statistical analysis was conducted to examine the relationships of these maternal and infant factors with the occurrence and severity of DRA. Results A total of 400 parturients were enrolled in this study. The incidence of DRA was 81.75% (327/400), including 171 cases of mild DRA (52.29%), 152 cases of mode-rate DRA (46.48%), and 4 cases of severe DRA (1.22%). Compared with the non-DRA group, the DRA group had higher neonatal birth weight (3 385 g vs. 3 190 g, P<0.001), a higher rate of cesarean section (114/327 vs. 13/73, P=0.005), and a higher proportion of women with parity >1 (89/327 vs. 11/73, P=0.030). No statistically significant differences were observed for other maternal or infant factors between the two groups. Binary logistic regression analysis showed that higher neonatal birth weight, cesarean section, and higher parity were independent risk factors for DRA (OR: 1.001, 2.549, and 2.053, respectively). Compared with the mild DRA group, the moderate DRA group had higher neonatal birth weight (3 401 g vs. 3 370 g, P=0.036), a higher rate of cesarean section (70/152 vs. 42/171, P<0.001), a higher proportion of women with parity greater than 1 (49/152 vs. 36/171, P=0.030), and a higher pre-delivery body mass index (BMI) (26 vs. 25, P=0.023). No statistically significant differences were observed for other parameters between the two groups. Conclusions The incidence of DRA among postpartum women is relatively high, with nearly half of the cases being moderate or severe, respectively. The two-step method using conventional two-dimensional ultrasonography is of significant clinical value for the timely detection of abnormalities. It facilitates the provision of timely and precise postpartum rehabilitation guidance tailored to different severity levels. Furthermore, this two-step method offers the advantages of simpler and more accurate delineation of the borders of the rectus abdominis. Maternal and infant risk factors, including neonatal birth weight, cesa-rean section, parity, and pre-delivery maternal BMI, affect the occurrence and severity of postpartum DRA.

    Figures and Tables | References | Related Articles | Metrics
    The value of capsule endoscopy combined with double-balloon enteroscopy in the diagnosis of small bowel diseases
    TANG Mingyu, TAN Yingying, CHEN Liping, YANG Jinmao, ZHONG Ling, CHEN Haiying, CHEN Huimin
    2025, 24 (06):  648-653.  DOI: 10.16150/j.1671-2870.2025.06.011
    Abstract ( 10 )   HTML ( 0 )   PDF (438KB) ( 9 )  

    Objective To analyze the diagnostic value of application of capsule endoscopy (CE) followed by double-balloon enteroscopy (DBE) in small bowel diseases, and to explore the diagnostic concordance between CE and DBE, thereby optimizing the examination workflow for patients with suspected small bowel lesions. Methods A retrospective analysis was conducted on the clinical data of 154 consecutive patients who underwent CE followed by DBE at Renji Hospital, Shanghai Jiao Tong University School of Medicine, between January 2020 and March 2025. The diagnostic concordance between the two examination modalities were assessed, and the influence of age and lesion type on concordance was analyzed. Results For the 154 patients who underwent CE followed by DBE in this study, the lesion detection rate of CE was higher than that of DBE [93.5%(144/154) vs 81.8%(126/154), χ2 = 8.53, P=0.003 5], and the detection rate of polyps/poly-poid hyperplasia by CE was higher than that by DBE (11.7% vs 5.2%, χ2=3.85, P=0.049). The detection rate of mass/submucosal lesions by DBE was higher than that by CE (5.84% vs 0.65%, χ2=6.4, P=0.011). Among the detected lesions, the detection rate of ulcerative diseases was highest (68/154), followed by inflammation/erosion, vascular malformation/blee-ding, polyps/polypoid hyperplasia, and mass/submucosal elevation. The overall diagnostic concordance between CE and DBE was moderate (κ=0.344, 95%CI 0.222-0.467, P<0.001), but higher concordance was observed for the diagnosis of ulcers (κ=0.55) and vascular malformation/bleeding (κ=0.42). After stratifying patients by age into 18 years (minors), 18-40 years (young adults), 40-59 years (middle-aged adults), and ≥60 years (elderly), the results of diagnostic consistency analysis showed that in the 40-59 years group, the diagnostic concordance rate between CE and DBE was 55.6% (κ=0.122), while in the 18-40 years group and the ≥60 years group, the diagnostic concordance rates were 46.20% (κ=0.447) and 44.10% (κ=0.446), respectively. Conclusions CE and DBE examinations are complementary in the diagnosis of small bowel diseases. CE can serve as a preliminary screening tool to optimize DBE examination. The sequentially combined application of the two can improve the diagnostic efficiency for small bowel vascular malformations and polyps. It is recommended to develop individualized sequential examination strategies based on patient age and lesion characteristics.

    Figures and Tables | References | Related Articles | Metrics
    Review articles
    Research progress on resistance mechanisms of group B Streptococcus to macrolides and lincosamide antibiotics
    SHEN Pinghua, CHEN Huifeng
    2025, 24 (06):  654-659.  DOI: 10.16150/j.1671-2870.2025.06.012
    Abstract ( 18 )   HTML ( 1 )   PDF (469KB) ( 13 )  

    Group B Streptococcus (GBS) is a major pathogen causing neonatal infection worldwide, and the colonization of GBS in the digestive and urogenital tracts of pregnant women is the main risk factor for neonatal infection. The global overall maternal GBS colonization rate is 18%, with 12.5% in South Asia, 11% in East Asia, and 11.3% in China. Without intervention, 50% of maternal GBS will be vertically transmitted to the fetus or neonate, which is a major cause of early-onset GBS disease in neonates and can lead to neonatal sepsis and neonatal meningitis. A study in 2015 indicated that neonatal invasive diseases caused by GBS infection globally resulted in 90 000 infant deaths, 3.5 million preterm births, and 57 000 stillbirths. Currently, some countries have adopted intrapartum antibiotic prophylaxis (IAP) to prevent the transmission of GBS from mother to neonate during delivery. In IAP, macrolide antibiotics such as erythromycin and lincosamide antibiotics such as clindamycin serve as second-line antibiotics and play an important role in anti-GBS infection. However, the resistance rates to antibiotics such as erythromycin and clindamycin remain high, with global resistance rates of approximately 25% and 27%, respectively. The resistance rates in China are even higher, at about 75% and 60%, respectively. The resistance mechanisms of GBS to the above two classes of antibiotics mainly include target modification, efflux pumps, ribosome protection by ABC-F proteins, and drug inactivation. These resistance mechanisms are increasingly diverse and mostly associated with mobile elements, accelerating the dissemination of resistance genes. There is an urgent need for clinicians and researchers to work together, strictly implement scientific management of antimicrobial drugs, and actively develop new antimicrobial agents, thereby preventing the spread of resistance genes.

    References | Related Articles | Metrics
    Case reports
    Pulmonary echinococcosis presenting with pleural effusion: a case report and literature review
    JIAO Tengfei, DONG Zhe, GULIFILALA·Aersulan , MA Shilin
    2025, 24 (06):  660-663.  DOI: 10.16150/j.1671-2870.2025.06.013
    Abstract ( 14 )   HTML ( 0 )   PDF (835KB) ( 12 )  

    Echinococcosis is a zoonotic disease that can cause various human diseases, among which pulmonary echinococcosis is relatively common. This paper reports one case of pulmonary echinococcosis in a patient with pleural effusion as the main manifestation. The patient was a 70-year-old female admitted to the hospital due to "right upper abdominal pain accompanied by chest tightness for 16 hours". Chest CT examination indicated right-sided hydropneumothorax, right lung atelectasis, and pulmonary exudative lesions. The pleural effusion was dark red and turbid, and the Rivalta's test was positive. Microscopic examination showed a large amount of fibrinous necrotic material and fungal-like spores. Pathological examination after thoracentesis suggested possible echinococcal infection. Considering the patient's history of hepatic echinococcosis and residence in a pastoral area, and combined with the diagnosis from an external hospital, the case was ultimately confirmed as pulmonary echinococcosis. This disease commonly occurs in children and young adults in pastoral areas, and patients have an epidemiological contact history such as contact with infected dogs. The infection is transmitted orally through ingestion of food or water contaminated with echinococcal eggs. Clinical features often include cough, chest pain, and hemoptysis. Cyst rupture into the pleural cavity can cause hydropneumothorax, pleural effusion, and allergic reactions. This reported case was an elderly patient with atypical clinical manifestations, characterized predominantly by pleural effusion. The patient eventually died due to the infection. This highlights that similar cases in echinococcosis-endemic areas should receive high clinical attention, especially among elderly patients.

    Figures and Tables | References | Related Articles | Metrics
    Blood type identification and molecular mechanism analysis of a novel RhD allele caused by c.767C>A mutation
    DAI Yuwan, YAN Beizhan, KONG Xiaoyang, GUO Xiuming, KONG Cunquan
    2025, 24 (06):  664-667.  DOI: 10.16150/j.1671-2870.2025.06.014
    Abstract ( 15 )   HTML ( 0 )   PDF (1367KB) ( 9 )  

    RhD-negative blood exhibits various phenotypes, each having multiple subtypes, and all associated with specific molecular mechanisms. This study reports a case involving a nucleotide variation at position 767 in exon 5 of the RhD gene (c.767C>A, p.Ser256Ter), resulting in the substitution of serine with a termination codon at position 256. These changes led to structural alterations in the RhD antigen protein, resulting in a serologically RhD-negative phenotype in the patient. The sequence data of this allele was reported for the first time and has been submitted to GenBank under the accession number PQ740962. For RhD-negative patients, serological and molecular biological methods should be further used to determine their subtypes and molecular genetic background. Different RhD blood types require differential management for pregnant women, transfusion recipients, and blood donors. Therefore, it is necessary to obtain more information for prenatal monitoring and transfusion management. This novel RhD allele mutation enriches the understanding of the molecular biological mechanisms underlying the formation of RhD-negative blood. It contributes to the accurate determination of RhD blood type and the development of "precision" blood transfusion guidance for clinical practice, thereby reducing transfusion risks for patients with rare blood types and ensuring transfusion safety.

    Figures and Tables | References | Related Articles | Metrics
    Medical education
    Application of artificial intelligence assisted blood cell morphology platform in teaching
    YU Mengsi, NING Conghua, MENG Cunren, Abdureimu PALIZATI, ZHONG Di, SHI Ying, XUE Li
    2025, 24 (06):  668-672.  DOI: 10.16150/j.1671-2870.2025.06.015
    Abstract ( 28 )   HTML ( 0 )   PDF (453KB) ( 15 )  
    Figures and Tables | References | Related Articles | Metrics